Table 3: Use of ECMO or IABP post-transplantation.
|
|
STS |
Celsior |
Celsior+EPO+GTN |
p-value |
|
ECMO or IABP (n, %) |
|
|
|
|
|
All transplants |
32
(32.0%) (32
IABP) |
33
(31.7%) (22
ECMO, 11 IABP) |
15
(24.6%) (13
ECMO, 2 IABP) |
ns |
|
|
|
|
|
|
|
Marginal
transplants |
17/44
(38.6%) (17
IABP) |
22/59
(37.2%) (16
ECMO, 6 IABP) |
10/34
(29.4%) (9
ECMO, 1 IABP) |
ns |
The use of extra-corporeal membrane
oxygenation (ECMO) or an intra-aortic balloon pump (IABP) within the first 24
hours post-transplant is shown above for all transplants and for marginal
transplants.